Digestives & Intestinal Remedies - Tanzania

  • Tanzania
  • In Tanzania, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$17.30m.
  • It is projected to experience an annual growth rate of 7.60% from 2024 to 2029 (CAGR 2024-2029).
  • When compared globally, in China generates the highest revenue in this market, reaching US$4,408.00m in 2024.
  • In terms of per capita figures, the revenue per person in Tanzania amounts to US$0.25 in 2024.
  • Sales of Digestives & Intestinal Remedies in the OTC Pharmaceuticals market in Tanzania are soaring, driven by growing awareness of digestive health and changing dietary habits.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Tanzania is experiencing steady growth due to increasing customer preferences for natural and herbal remedies, as well as the rising awareness and prevalence of digestive health issues in the country.

Customer preferences:
Customers in Tanzania are increasingly turning to natural and herbal remedies for digestive health issues. This shift in preferences can be attributed to the rising awareness of the potential side effects of conventional medications and the desire for more holistic and sustainable solutions. Additionally, there is a growing demand for products that are locally sourced and produced, as customers place importance on supporting local businesses and the economy.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Tanzania is the increasing demand for probiotics and dietary supplements. Probiotics are known for their positive effects on gut health and are becoming more popular among consumers seeking to improve their digestive function. Dietary supplements, such as fiber supplements, are also gaining traction as they are seen as an effective way to address common digestive issues.Another trend in the market is the rise of herbal remedies. Traditional herbal medicine has a long history in Tanzania, and many consumers are turning to herbal remedies for digestive health issues. This trend is driven by the belief that herbal remedies are natural, safe, and have fewer side effects compared to conventional medications.

Local special circumstances:
Tanzania has a rich biodiversity, with a wide range of medicinal plants that have been traditionally used for digestive health issues. This abundance of natural resources provides an opportunity for local manufacturers to develop and produce herbal remedies that cater to the specific needs of the Tanzanian market. Additionally, the government has been supportive of the traditional medicine sector, providing incentives and regulations to promote the development and use of herbal remedies.

Underlying macroeconomic factors:
The growth of the Digestives & Intestinal Remedies market in Tanzania is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has led to an increase in disposable income and improved access to healthcare services. As a result, consumers are more willing to spend on healthcare products, including those for digestive health.Furthermore, the increasing prevalence of digestive health issues in Tanzania is driving the demand for Digestives & Intestinal Remedies. Factors such as changes in diet, stress, and sedentary lifestyles contribute to the rising incidence of digestive disorders, creating a need for effective remedies.In conclusion, the Digestives & Intestinal Remedies market in Tanzania is growing due to customer preferences for natural and herbal remedies, the increasing demand for probiotics and dietary supplements, the rich biodiversity of the country, and the underlying macroeconomic factors such as economic growth and the rising prevalence of digestive health issues.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)